CD8A and cancer: Moreover, we found that high-risk patients showed a significantly decreased tumor-associated macrophage (TAM) M2 score (Figure S7C, P<0.001) and a significantly increased myeloid-derived suppressor cell (MDSC) score (Figure S7D, P<0.001), cancer-associated fibroblast (CAF) score (Figure S7E, P<0.05), and CD8 score (Figure S7F, P<0.001).